Actualizaciones regulatorias
Novedades regulatorias de FDA, EMA, TGA y organismos globales
#Mometasone Furoate ×
Actualizaciones regulatorias
15 sept 2026•3 min de lectura
FDA Grants ANDA Approval for Mometasone Furoate Topical Lotion (ANDA077678)
The FDA approved an ANDA (ANDA077678) for a 0.1% mometasone furoate topical lotion submitted by Cosette Pharms NC; the product is listed as discontinued.
Actualizaciones regulatorias
15 sept 2026•3 min de lectura
FDA Approves Sun Pharma Canada ANDA for Mometasone Furoate Topical Lotion
FDA approved ANDA076788 for a Mometasone Furoate 0.1% topical lotion by Sun Pharma Canada; the product is listed as discontinued, with labeling supplements approved in 2015 and 2019.
Actualizaciones regulatorias
15 sept 2026•3 min de lectura
Glenmark Pharm's Mometasone Furoate Ointment (ANDA078571) Receives Multiple Labeling Approvals
The FDA approved the original ANDA for Glenmark's Mometasone Furoate topical ointment on May 28, 2008, and later granted labeling supplements in 2015 and 2024; the product is now discontinued.